Terry A. Beerman - Publications

Affiliations: 
State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Molecular Biology, Pharmaceutical Chemistry

91 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Beerman TA, Gawron LS, Shen B, Kennedy DR. The radiomimetic enediyne, 20'-deschloro-C-1027 induces inter-strand DNA crosslinks in hypoxic cells and overcomes cytotoxic radioresistance. Dna Repair. 21: 165-70. PMID 24986640 DOI: 10.1016/j.dnarep.2014.06.001  0.6
2012 San Pedro JM, Beerman TA, Greenberg MM. DNA damage by C1027 involves hydrogen atom abstraction and addition to nucleobases. Bioorganic & Medicinal Chemistry. 20: 4744-50. PMID 22748380 DOI: 10.1016/j.bmc.2012.06.004  0.6
2009 McHugh MM, Beerman TA. An extraction-free method by which a single slot blot can be used to quantify intracellular DNA damage (crosslinks or strand breaks) and changes in DNA damage response proteins or replication Biotechniques. 46: 127-129. PMID 19317657 DOI: 10.2144/000113046  0.6
2009 Beerman TA, Gawron LS, Shin S, Shen B, McHugh MM. C-1027, a radiomimetic enediyne anticancer drug, preferentially targets hypoxic cells. Cancer Research. 69: 593-8. PMID 19147573 DOI: 10.1158/0008-5472.CAN-08-2753  0.6
2007 Kennedy DR, Ju J, Shen B, Beerman TA. Designer enediynes generate DNA breaks, interstrand cross-links, or both, with concomitant changes in the regulation of DNA damage responses. Proceedings of the National Academy of Sciences of the United States of America. 104: 17632-7. PMID 17978180 DOI: 10.1073/pnas.0708274104  0.6
2007 Kennedy DR, Gawron LS, Ju J, Liu W, Shen B, Beerman TA. Single chemical modifications of the C-1027 enediyne core, a radiomimetic antitumor drug, affect both drug potency and the role of ataxia-telangiectasia mutated in cellular responses to DNA double-strand breaks. Cancer Research. 67: 773-81. PMID 17234789 DOI: 10.1158/0008-5472.CAN-06-2893  0.6
2006 Dziegielewska B, Beerman TA, Bianco PR. Inhibition of RecBCD enzyme by antineoplastic DNA alkylating agents. Journal of Molecular Biology. 361: 898-919. PMID 16887143 DOI: 10.1016/j.jmb.2006.06.068  0.6
2006 Kennedy DR, Beerman TA. The radiomimetic enediyne C-1027 induces unusual DNA damage responses to double-strand breaks. Biochemistry. 45: 3747-54. PMID 16533058 DOI: 10.1021/bi052334c  0.6
2005 Tu LC, Matsui SI, Beerman TA. Hedamycin, a DNA alkylator, induces (gamma)H2AX and chromosome aberrations: involvement of phosphatidylinositol 3-kinase-related kinases and DNA replication fork movement. Molecular Cancer Therapeutics. 4: 1175-85. PMID 16093433 DOI: 10.1158/1535-7163.MCT-05-0054  0.6
2005 McHugh MM, Gawron LS, Matsui S, Beerman TA. The antitumor enediyne C-1027 alters cell cycle progression and induces chromosomal aberrations and telomere dysfunction. Cancer Research. 65: 5344-51. PMID 15958582 DOI: 10.1158/0008-5472.CAN-05-0015  0.6
2005 Philips BJ, Chang AY, Dervan PB, Beerman TA. DNA damage effects of a polyamide-CBI conjugate in SV40 virions. Molecular Pharmacology. 67: 877-82. PMID 15576630 DOI: 10.1124/mol.104.006254  0.6
2004 Dziegielewska B, Kowalski D, Beerman TA. SV40 DNA replication inhibition by the monofunctional DNA alkylator Et743. Biochemistry. 43: 14228-37. PMID 15518573 DOI: 10.1021/bi049407x  0.6
2004 Tu LC, Melendy T, Beerman TA. DNA damage responses triggered by a highly cytotoxic monofunctional DNA alkylator, hedamycin, a pluramycin antitumor antibiotic. Molecular Cancer Therapeutics. 3: 577-85. PMID 15141015  0.6
2003 Wang YD, Dziegielewski J, Wurtz NR, Dziegielewska B, Dervan PB, Beerman TA. DNA crosslinking and biological activity of a hairpin polyamide-chlorambucil conjugate. Nucleic Acids Research. 31: 1208-15. PMID 12582240 DOI: 10.1093/nar/gkg215  0.6
2003 Liu JS, Kuo SR, Beerman TA, Melendy T. Induction of DNA damage responses by adozelesin is S phase-specific and dependent on active replication forks Molecular Cancer Therapeutics. 2: 41-47. PMID 12533671  0.6
2002 Wang YD, Dziegielewski J, Chang AY, Dervan PB, Beerman TA. Cell-free and cellular activities of a DNA sequence selective hairpin polyamide-CBI conjugate. The Journal of Biological Chemistry. 277: 42431-7. PMID 12196541 DOI: 10.1074/jbc.M207179200  0.6
2002 Belitsky JM, Leslie SJ, Arora PS, Beerman TA, Dervan PB. Cellular uptake of N-methylpyrrole/N-methylimidazole polyamide-dye conjugates. Bioorganic & Medicinal Chemistry. 10: 3313-8. PMID 12150878 DOI: 10.1016/S0968-0896(02)00204-3  0.6
2002 White CM, Satz AL, Gawron LS, Bruice TC, Beerman TA. Inhibiting transcription factor/DNA complexes using fluorescent microgonotropens (FMGTs). Biochimica Et Biophysica Acta. 1574: 100-8. PMID 11955618 DOI: 10.1016/S0167-4781(01)00351-7  0.6
2002 Dziegielewski J, Beerman TA. Cellular responses to the DNA strand-scission enediyne C-1027 can be independent of ATM, ATR, and DNA-PK kinases. The Journal of Biological Chemistry. 277: 20549-54. PMID 11927575 DOI: 10.1074/jbc.M109897200  0.6
2001 Liu JS, Kuo SR, Yin X, Beerman TA, Melendy T. DNA damage by the enediyne C-1027 results in the inhibition of DNA replication by loss of replication protein A function and activation of DNA-dependent protein kinase Biochemistry. 40: 14661-14668. PMID 11724580 DOI: 10.1021/bi015680c  0.6
2001 White CM, Satz AL, Bruice TC, Beerman TA. Inhibition of transcription factor-DNA complexes and gene expression by a microgonotropen. Proceedings of the National Academy of Sciences of the United States of America. 98: 10590-5. PMID 11535831 DOI: 10.1073/pnas.191374698  0.6
2001 Satz AL, White CM, Beerman TA, Bruice TC. Double-stranded DNA binding characteristics and subcellular distribution of a minor groove binding diphenyl ether bisbenzimidazole. Biochemistry. 40: 6465-74. PMID 11371210 DOI: 10.1021/bi0103415  0.6
2001 Wang Y, Beerman TA, Kowalski D. Antitumor drug adozelesin differentially affects active and silent origins of DNA replication in yeast checkpoint kinase mutants Cancer Research. 61: 3787-3794. PMID 11325853  0.6
2001 McHugh MM, Yin X, Kuo SR, Liu JS, Melendy T, Beerman TA. The cellular response to DNA damage induced by the enediynes C-1027 and neocarzinostatin includes hyperphosphorylation and increased nuclear retention of replication protein A (RPA) and trans inhibition of DNA replication Biochemistry. 40: 4792-4799. PMID 11294647 DOI: 10.1021/bi001668t  0.6
2001 Dziegielewski J, Melendy T, Beerman TA. Bleomycin-induced alterations in DNA replication: relationship to DNA damage. Biochemistry. 40: 704-11. PMID 11170387 DOI: 10.1021/bi002181n  0.6
2000 White CM, Heidenreich O, Nordheim A, Beerman TA. Evaluation of the effectiveness of DNA-binding drugs to inhibit transcription using the c-fos serum response element as a target. Biochemistry. 39: 12262-73. PMID 11015205 DOI: 10.1021/bi001427l  0.6
2000 Chiang SY, Burli RW, Benz CC, Gawron L, Scott GK, Dervan PB, Beerman TA. Targeting the ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides. The Journal of Biological Chemistry. 275: 24246-54. PMID 10818092 DOI: 10.1074/jbc.M000820200  0.6
2000 Liu JS, Kuo SR, McHugh MM, Beerman TA, Melendy T. Adozelesin triggers DNA damage response pathways and arrests SV40 DNA replication through replication protein A inactivation Journal of Biological Chemistry. 275: 1391-1397. PMID 10625690 DOI: 10.1074/jbc.275.2.1391  0.6
1999 McHugh MM, Kuo SR, Walsh-O'Beirne MH, Liu JS, Melendy T, Beerman TA. Bizelesin, a bifunctional cyclopropylpyrroloindole alkylating agent, inhibits simian virus 40 replication in trans by induction of an inhibitor Biochemistry. 38: 11508-11515. PMID 10471303 DOI: 10.1021/bi990598r  0.6
1999 McHugh MM, Beerman TA. C-1027-induced alterations in Epstein-Barr viral DNA replication in latently infected cultured human Raji cells: Relationship to DNA damage Biochemistry. 38: 6962-6970. PMID 10346918 DOI: 10.1021/bi9903143  0.6
1999 McHugh MM, Beerman TA. Purification of large quantities of high-molecular-weight Epstein-Barr viral and cellular genomic DNA from cultured human Raji cells Biotechniques. 26: 188-194. PMID 10023522  0.6
1998 Chiang SY, Azizkhan JC, Beerman TA. A comparison DNA-binding drug as inhibitors of E2F1- and Sp1-DNA complexes and associated gene expression Biochemistry. 37: 3109-3115. PMID 9485464 DOI: 10.1021/bi9721142  0.6
1997 Woynarowski JM, Beerman TA. Effects of bizelesin (U-77,779), a bifunctional alkylating minor groove binder, on replication of genomic and simian virus 40 DNA in BSC-1 cells Biochimica Et Biophysica Acta - Gene Structure and Expression. 1353: 50-60. PMID 9256064 DOI: 10.1016/S0167-4781(97)00046-8  0.6
1997 Tatarowicz WA, Martin CE, Pekosz AS, Madden SL, Rauscher FJ, Chiang SY, Beerman TA, Fraser NW. Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: involvement of a binding site immediately downstream of the TATA box. Journal of Neurovirology. 3: 212-24. PMID 9200069  0.6
1997 Bruice TC, Sengupta D, Blaskó A, Chiang SY, Beerman TA. A microgonotropen branched decaaza decabutylamine and its DNA and DNA/transcription factor interactions. Bioorganic & Medicinal Chemistry. 5: 685-92. PMID 9158867 DOI: 10.1016/S0968-0896(97)00011-4  0.6
1997 Kirk CA, Goodisman J, Beerman TA, Gawron LS, Dabrowiak JC. Kinetics of cleavage of intra- and extracellular simian virus 40 DNA with the enediyne anticancer drug C-1027. Biophysical Chemistry. 63: 201-9. PMID 9108692 DOI: 10.1016/S0301-4622(96)02217-X  0.6
1997 Chiang SY, Bruice TC, Azizkhan JC, Gawron L, Beerman TA. Targeting E2F1-DNA complexes with microgonotropen DNA binding agents. Proceedings of the National Academy of Sciences of the United States of America. 94: 2811-6. PMID 9096302 DOI: 10.1073/pnas.94.7.2811  0.6
1997 McHugh MM, Beerman TA, Burhans WC. DNA-damaging enediyne C-1027 inhibits initiation of intracellular SV40 DNA replication in trans Biochemistry. 36: 1003-1009. PMID 9033389 DOI: 10.1021/bi962121a  0.6
1996 Chiangt SY, Welch JJ, Rauscher FJ, Beerman TA. Effect of DNA-binding drugs on early growth response factor-1 and TATA box-binding protein complex formation with the herpes simplex virus latency promoter Journal of Biological Chemistry. 271: 23999-24004. PMID 8798634 DOI: 10.1074/jbc.271.39.23999  0.6
1996 Cobuzzi RJ, Burhanst WC, Beerman TA. Inhibition of initiation of simian virus 40 DNA replication in infected BSC-1 cells by the DNA alkylating drug adozelesin Journal of Biological Chemistry. 271: 19852-19859. PMID 8702695 DOI: 10.1074/jbc.271.33.19852  0.6
1995 McHugh MM, Woynarowski JM, Gawron LS, Otani T, Beerman TA. Effects of the DNA-damaging enediyne C-1027 on intracellular SV40 and genomic DNA in green monkey kidney BSC-1 cells Biochemistry. 34: 1805-1814. PMID 7849041  0.6
1995 Cobuzzi RJ, Kotsopoulos SK, Otani T, Beerman TA. Effects of the enediyne C-1027 on intracellular DNA targets Biochemistry. 34: 583-592. PMID 7819253  0.6
1995 Woynarowski JM, McHugh MM, Gawron LS, Beerman TA. Effects of bizelesin (U-77779), a bifunctional alkylating minor groove agent, on genomic and simian virus 40 DNA Biochemistry. 34: 13042-13050. PMID 7548063  0.6
1994 Woynarowski JM, McCarthy K, Reynolds B, Beerman TA, Denny WA. Topoisomerase II mediated DNA lesions induced by acridine-4-carboxamide and 2-(4-pyridyl)quinoline-8-carboxamide. Anti-Cancer Drug Design. 9: 9-24. PMID 8141968  0.6
1994 McHugh MM, Woynarowski JM, Mitchell MA, Gawron LS, Weiland KL, Beerman TA. CC-1065 bonding to intracellular and purified SV40 DNA: Site specificity and functional effects Biochemistry. 33: 9158-9168. PMID 8049219  0.6
1994 Welch JJ, Rauscher FJ, Beerman TA. Targeting DNA-binding drugs to sequence-specific transcription factor-DNA complexes. Differential effects of intercalating and minor groove binding drugs Journal of Biological Chemistry. 269: 31051-31058. PMID 7983044  0.6
1994 Johnson PG, Beerman TA. Damage induced in episomal EBV DNA in Raji cells by antitumor drugs as measured by pulsed field gel electrophoresis Analytical Biochemistry. 220: 103-114. PMID 7526729 DOI: 10.1006/abio.1994.1305  0.6
1994 Chiang SY, Welch J, Rauscher FJ, Beerman TA. Effects of minor groove binding drugs on the interaction of TATA box binding protein and TFIIA with DNA Biochemistry. 33: 7033-7040. PMID 7516181 DOI: 10.1021/bi00189a003  0.6
1992 Beerman TA, McHugh MM, Sigmund R, Lown JW, Rao KE, Bathini Y. Effects of analogs of the DNA minor groove binder Hoechst 33258 on topoisomerase II and I mediated activities. Biochimica Et Biophysica Acta. 1131: 53-61. PMID 1374646 DOI: 10.1016/0167-4781(92)90098-K  0.6
1992 Zsido TJ, Beerman TA, Meegan RL, Woynarowski JM, Baker RM. Resistance of CHO cells expressing P-glycoprotein to cyclopropylpyrroloindole (CPI) alkylating agents Biochemical Pharmacology. 43: 1817-1822. PMID 1349478 DOI: 10.1016/0006-2952(92)90715-U  0.6
1991 Ferrazzi E, Woynarowski JM, Arakali A, Brenner DE, Beerman TA. DNA damage and cytotoxicity induced by metabolites of anthracycline antibiotics, doxorubicin and idarubicin. Cancer Communications. 3: 173-80. PMID 2049226  0.6
1991 Vertino PM, Beerman TA, Kelly EJ, Bergeron RJ, Porter CW. Selective cellular depletion of mitochondrial DNA by the polyamine analog N1,N12-bis(ethyl)spermine and its relationship to polyamine structure and function. Molecular Pharmacology. 39: 487-94. PMID 2017149  0.6
1991 Zsido TJ, Woynarowski JM, Baker RM, Gawron LS, Beerman TA. Induction of heat-labile sites in DNA of mammalian cells by the antitumor alkylating drug CC-1065 Biochemistry. 30: 3733-3738. PMID 1849736  0.6
1991 Cullinan EB, Gawron LS, Rustum YM, Beerman TA. Extrachromosomal chromatin: Novel target for bleomycin cleavage in cells and solid tumors Biochemistry. 30: 3055-3061. PMID 1706627  0.6
1991 Beerman TA, Woynarowski JM, Sigmund RD, Gawron LS, Rao KE, Lown JW. Netropsin and bis-netropsin analogs as inhibitors of the catalytic activity of mammalian DNA topoisomerase II and topoisomerase cleavable complexes Bba - Gene Structure and Expression. 1090: 52-60. PMID 1653020 DOI: 10.1016/0167-4781(91)90036-L  0.6
1990 Cullinan EB, Gawron LS, Rustum YM, Beerman TA. Topoisomerase II-mediated DNA Damage of Episomes in Tumor-bearing Mice Cancer Research. 50: 6154-6157. PMID 2169334  0.6
1990 Rauscher FJ, Beerman TA, Baker RM. Characterization of auromomycin-resistant hamster cell mutants that display a multidrug resistance phenotype Molecular Pharmacology. 38: 198-206. PMID 2143555  0.6
1990 McHugh MM, Sigmund RD, Beerman TA. Effects of minor groove binding drugs on camptothecin-induced DNA lesions in L1210 nuclei Biochemical Pharmacology. 39: 707-714. PMID 1689578 DOI: 10.1016/0006-2952(90)90149-F  0.6
1989 Van Roey P, Beerman TA. Crystal structure analysis of auromomycin apoprotein (macromomycin) shows importance of protein side chains to chromophore binding selectivity Proceedings of the National Academy of Sciences of the United States of America. 86: 6587-6591. PMID 2771945  0.6
1989 Woynarowski JM, McNamee H, Szmigiero L, Beerman TA, Konopa J. Induction of DNA-protein crosslinks by antitumor 1-nitro-9-aminoacridines in L1210 leukemia cells Biochemical Pharmacology. 38: 4095-4101. PMID 2557039 DOI: 10.1016/0006-2952(89)90691-6  0.6
1989 Cullinan EB, Beerman TA. A study of drug-induced topoisomerase II-mediated DNA lesions on episomal chromatin Journal of Biological Chemistry. 264: 16268-16275. PMID 2550434  0.6
1989 Woynarowski JM, Sigmund RD, Beerman TA. DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells Biochemistry. 28: 3850-3855. PMID 2473776  0.6
1989 McHugh MM, Woynarowski JM, Sigmund RD, Beerman TA. Effect of minor groove binding drugs on mammalian topoisomerase I activity Biochemical Pharmacology. 38: 2323-2328. PMID 2473754 DOI: 10.1016/0006-2952(89)90472-3  0.6
1989 Beckmann RP, Beerman TA. Use of an inducible hybrid viral gene as a model for evaluating drug effects on gene expression Molecular Pharmacology. 35: 433-442. PMID 2468078  0.6
1989 Woynarowski JM, McHugh M, Sigmund RD, Beerman TA. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole Molecular Pharmacology. 35: 177-182. PMID 2465485  0.6
1989 Woynarowski JM, Beerman TA. Preferential effect of bleomycin on newly replicated chromatin in nuclei from L1210 cells Bba - Gene Structure and Expression. 1007: 116-119. PMID 2462448 DOI: 10.1016/0167-4781(89)90139-5  0.6
1988 Grimwade JE, Cullinan EB, Beerman TA. Neocarzinostatin and auromomycin preferentially cleave simian virus 40 DNA and chromosomes at a number of discrete locations Bba - Gene Structure and Expression. 950: 102-112. PMID 2838085 DOI: 10.1016/0167-4781(88)90002-4  0.6
1988 Woynarowski JM, Sigmund RD, Beerman TA. Topoisomerase-II-mediated lesions in nascent DNA: Comparison of the effects of epipodophyllotoxin derivatives, VM-26 and VP-16, and 9-anilinoacridine derivatives, m-AMSA and o-AMSA Bba - Gene Structure and Expression. 950: 21-29. PMID 2833925 DOI: 10.1016/0167-4781(88)90069-3  0.6
1987 Woynarowski JM, Gawron LS, Beerman TA. Bleomycin-induced aggregation of presolubilized and nuclear chromatin from L1210 cells Bba - Gene Structure and Expression. 910: 149-156. PMID 2445383 DOI: 10.1016/0167-4781(87)90067-4  0.6
1987 Beckmann RP, Agostino MJ, McHugh MM, Sigmund RD, Beerman TA. Assessment of preferential cleavage of an actively transcribed retroviral hybrid gene in murine cells by deoxyribonuclease I, bleomycin, neocarzinostatin, or ionizing radiation Biochemistry. 26: 5409-5415. PMID 2445373  0.6
1987 Griinwade JE, Cason EB, Beerman TA. Site specificity of bleomycin cleavage in purified and intracellular simian virus 40 DNA Nucleic Acids Research. 15: 6315-6329. PMID 2442726 DOI: 10.1093/nar/15.16.6315  0.6
1986 Grimwade JE, Beerman TA. Measurement of bleomycin, neocarzinostatin, and auromomycin cleavage of cell-free and intracellular simian virus 40 DNA and chromatin Molecular Pharmacology. 30: 358-363. PMID 2429169  0.6
1985 Pavelic K, Beerman TA, Bernacki RJ. An evaluation of the effects of combination chemotherapy in vitro using DNA-reactive agents Cancer Drug Delivery. 2: 255-270. PMID 2415231  0.6
1984 Agostino MJ, Bernacki RJ, Beerman TA. Synergistic interactions of ethidium bromide and bleomycin on cellular DNA and growth inhibition Biochemical and Biophysical Research Communications. 120: 156-163. PMID 6201171 DOI: 10.1016/0006-291X(84)91427-X  0.6
1983 Beerman TA, Mueller G, Grimmond H. Effects of neocarzinostatin on chromatin in HeLa S3 nuclei Molecular Pharmacology. 23: 493-499. PMID 6220204  0.6
1982 Fiel RJ, Beerman TA, Mark EH, Datta-Gupta N. DNA strand scission activity of metalloporphyrins Biochemical and Biophysical Research Communications. 107: 1067-1074. PMID 7138512 DOI: 10.1016/0006-291X(82)90630-1  0.6
1981 Van Roey P, Weeks CM, DeJarnette FE, Beerman TA, McHugh M. Preliminary crystallographic study of macromomycin. The apoprotein of the antitumor antibiotic auromomycin Journal of Molecular Biology. 153: 183-185. PMID 7338912 DOI: 10.1016/0022-2836(81)90534-9  0.6
1981 Woynarowski JW, Beerman TA, Konopa J. Induction of deoxyribonucleic acid damage in HeLa S3 cells by cytotoxic and antitumor sesquiterpene lactones Biochemical Pharmacology. 30: 3005-3007. PMID 7317096 DOI: 10.1016/0006-2952(81)90268-9  0.6
1980 Woynarowski JM, Beerman TA. Inhibition of DNA replication in HeLa S3 cells by macromomycin-I, an antitumor protein antibiotic Molecular Pharmacology. 18: 491-496. PMID 7464814  0.6
1980 Woynarowski JM, Beerman TA. Purification and characterization of macromomycin-I, a protein antibiotic containing a non-protein chromophore Biochemical and Biophysical Research Communications. 94: 769-776. PMID 7396932 DOI: 10.1016/0006-291X(80)91301-7  0.6
1980 Beerman TA, Gutai MW. DNA damage in neocarzinostatin-, macromomycin-, and bleomycin-treated SV40 virions Molecular Pharmacology. 17: 388-394. PMID 6156402  0.6
1979 Beerman TA. Strand scission of superhelical and linear duplex DNAs by the antitumor protein macromomycin. Relationship of in vitro DNA damage to cell growth inhibition Bba Section Nucleic Acids and Protein Synthesis. 564: 361-371. PMID 159074 DOI: 10.1016/0005-2787(79)90028-5  0.6
1978 Beerman TA. Cellular DNA damage by the antitumor protein macromomycin and its relationship to cell growth inhibition Biochemical and Biophysical Research Communications. 83: 908-914. PMID 708441 DOI: 10.1016/0006-291X(78)91481-X  0.6
1978 Goldberg IH, Kappen LS, Beerman TA. The nature and mechanism of the damage induced in DNA by a protein antibiotic Advances in Enzyme Regulation. 16: 239-254. PMID 151496 DOI: 10.1016/0065-2571(78)90076-6  0.6
1977 Poon R, Beerman TA, Goldberg IH. Characterization of DNA strand breakage in vitro by the antitumor protein neocarzinostatin Biochemistry. 16: 486-493. PMID 189801  0.6
1977 Beerman TA, Poon R, Goldberg IH. Single-strand nicking of DNA in vitro by neocarzinostatin and its possible relationship to the mechanism of drug action Bba Section Nucleic Acids and Protein Synthesis. 475: 294-306. PMID 139167 DOI: 10.1016/0005-2787(77)90020-X  0.6
1977 Beerman TA, Goldberg IH. The relationship between DNA strand-scission and DNA synthesis inhibition in HeLa cells treated with neocarzinostatin Bba Section Nucleic Acids and Protein Synthesis. 475: 281-293. PMID 139166 DOI: 10.1016/0005-2787(77)90019-3  0.6
1976 Beerman TA, Goldberg IH, Kappen LS, Poon R, Suzuki H. Molecular basis of action of cytotoxic antibiotics Advances in Enzyme Regulation. 14: 207-225. PMID 9788 DOI: 10.1016/0065-2571(76)90014-5  0.6
1975 Beerman TA, Goldberg IH, Poon R. The interaction of the protein antibiotic neocarzinostatin with DNA Excerpta Medica, Ics No. 353. 347-352.  0.6
1974 Beerman TA, Goldberg IH. DNA strand scission by the antitumor protein neocarzinostatin Biochemical and Biophysical Research Communications. 59: 1254-1261. PMID 4369938 DOI: 10.1016/0006-291X(74)90449-5  0.6
1973 Beerman TA, Lebowitz J. Further analysis of the altered secondary structure of superhelical DNA. Sensitivity to methylmercuric hydroxide a chemical probe for unpaired bases Journal of Molecular Biology. 79. PMID 4758062 DOI: 10.1016/0022-2836(73)90398-7  0.6
Show low-probability matches.